An elderly woman looking off into the distance.
An elderly woman looking off into the distance.

Investor Relations

Investor Relations represents MorphoSys and its equity story to the financial market and supports the Company's overall strategic communication. Through active and transparent investor relations work, the aim is to enable investors to make an informed decision of the Company.

Annual Report and Non-Financial Group Report 2022

Non-financial Group Report 2022 Desktop
Annual Report 2022 Mobile

Annual Report 2022

We offer insight into our company story, mission, group management report, financial statements, clinical pipeline and more. 

Annual Report 2022 Desktop
Annual Report 2022 Mobile

Non-Financial Group Report 2022

We provide information on business ethics, compliance and social, employee and environmental matters. 

Events & Conferences

13 Jun 2023

Goldman Sachs 44th Annual Global Healthcare Conference (Dana Point, CA, USA)

In Person Save the date
22 Jun 2023

Citi's European Healthcare Conference

Virtual Save the date
29 Jun 2023

Stifel, European Healthcare Summit (Bordeaux, France)

In Person Save the date

INVESTOR INFORMATION

Financial Information

Financial Information

Take a closer look at our Financial Guidance 2023 and the Fundamentals of MorphoSys.

Annual General Meeting

The virtual Annual General Meeting 2022 of MorphoSys AG.

Stock

Stock Information

MorphoSys stock information in detail.

Corporate Governance

We believe that our commitment to high Corporate Governance standards will ultimately increase shareholder value.

clinical trials
Clinical trials

Our Understanding of Sustainability

We are conscious of the responsibility we share for present and future generations and see sustainable action as a prerequisite for long-term business success.

Investor Contact

JNE

DR. JULIA NEUGEBAUER

HEAD OF INVESTOR RELATIONS

Tel. +49 89 89927 179
Julia.Neugebauer@morphosys.com